Clinical trials: Type 2 Bipolar Disorder

Bipolar Depression

Vortioxetine Adjunctive Treatment in Bipolar Depression

• Completed
• Age: 14 to 45 years
• Phase 4

Depressive episode of bipolar disorder is often the first symptom of patients with bipolar disorder, which is characterized by frequent recurrence, relatively long duration, high comorbidity rate and high fatality rate.

Trial name

Vortioxetine (NCT05481957)

Testing

Vortioxetine, valprote

Where

China

Volunteers

131 people

Sponsor

First Affiliated Hospital of Zhejiang University